Jump Financial LLC Buys 626,496 Shares of Hims & Hers Health, Inc. $HIMS

Key Points

• Jump Financial LLC significantly increased its stake in Hims & Hers Health, acquiring 626,496 additional shares, representing a 633.2% boost in ownership during the first quarter.
• Hims & Hers Health reported earnings per share of $0.17 for the latest quarter, slightly missing market expectations, while its revenue saw a 72.6% year-over-year increase.
• The stock has received mixed ratings from analysts, with a consensus target price of $38.92 and a current consensus rating categorized as "Reduce."

Jump Financial LLC boosted its stake in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 633.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 725,445 shares of the company's stock after acquiring an additional 626,496 shares during the period. Jump Financial LLC owned 0.32% of Hims & Hers Health worth $21,437,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Signaturefd LLC lifted its stake in Hims & Hers Health by 17.7% during the first quarter. Signaturefd LLC now owns 2,586 shares of the company's stock valued at $76,000 after buying an additional 388 shares in the last quarter. GAMMA Investing LLC increased its holdings in Hims & Hers Health by 128.5% in the first quarter. GAMMA Investing LLC now owns 5,143 shares of the company's stock worth $152,000 after buying an additional 2,892 shares during the last quarter. New York State Teachers Retirement System increased its holdings in Hims & Hers Health by 95.2% in the first quarter. New York State Teachers Retirement System now owns 194,795 shares of the company's stock worth $5,756,000 after buying an additional 94,983 shares during the last quarter. BNP Paribas Financial Markets acquired a new position in Hims & Hers Health in the fourth quarter worth approximately $1,230,000. Finally, Fifth Third Bancorp grew its holdings in Hims & Hers Health by 165.4% during the first quarter. Fifth Third Bancorp now owns 1,542 shares of the company's stock valued at $46,000 after purchasing an additional 961 shares during the last quarter. Institutional investors own 63.52% of the company's stock.

Insider Transactions at Hims & Hers Health

In other news, insider Patrick Harrison Carroll sold 60,000 shares of the business's stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $53.58, for a total transaction of $3,214,800.00. Following the completion of the transaction, the insider directly owned 169,940 shares in the company, valued at approximately $9,105,385.20. The trade was a 26.09% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Soleil Boughton sold 2,572 shares of the business's stock in a transaction that occurred on Monday, August 11th. The shares were sold at an average price of $51.64, for a total value of $132,818.08. Following the completion of the transaction, the insider owned 153,021 shares of the company's stock, valued at $7,902,004.44. This represents a 1.65% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 1,396,090 shares of company stock valued at $71,927,627 in the last three months. Company insiders own 17.71% of the company's stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on HIMS. Needham & Company LLC restated a "hold" rating on shares of Hims & Hers Health in a research note on Tuesday, August 5th. TD Cowen downgraded shares of Hims & Hers Health from a "buy" rating to a "hold" rating and lowered their price objective for the stock from $44.00 to $30.00 in a research note on Tuesday, April 29th. Zacks Research cut Hims & Hers Health from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, August 19th. UBS Group set a $30.00 target price on Hims & Hers Health in a research report on Monday, June 23rd. Finally, Truist Financial reduced their target price on Hims & Hers Health from $48.00 to $37.00 and set a "hold" rating for the company in a research report on Monday, August 18th. Two analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Reduce" and an average price target of $38.92.

Hims & Hers Health Price Performance

Shares of Hims & Hers Health stock traded up $0.57 during trading on Friday, reaching $44.53. The company's stock had a trading volume of 27,930,748 shares, compared to its average volume of 33,304,326. The stock has a 50-day moving average price of $51.71 and a two-hundred day moving average price of $45.85. The company has a current ratio of 4.98, a quick ratio of 4.46 and a debt-to-equity ratio of 1.72. Hims & Hers Health, Inc. has a one year low of $13.47 and a one year high of $72.98. The stock has a market capitalization of $10.06 billion, a P/E ratio of 55.66, a price-to-earnings-growth ratio of 3.01 and a beta of 2.08.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.18 by ($0.01). The business had revenue of $544.83 million during the quarter, compared to the consensus estimate of $550.06 million. Hims & Hers Health had a net margin of 9.63% and a return on equity of 26.26%. The business's quarterly revenue was up 72.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.06 earnings per share. Hims & Hers Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, sell-side analysts anticipate that Hims & Hers Health, Inc. will post 0.29 EPS for the current fiscal year.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.